ALTURiX acquires exclusive UK rights to three new products
The new products are in the areas of gastrointestinal and respiratory medicines
Read More
Tag: ALTURiX
ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
Read More
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
